Mizuho Securities USA’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.97M Buy
116,365
+26,710
+30% +$1.45M 0.08% 238
2026
Q1
$5.63M Sell
89,655
-18,287
-17% -$1.46M 0.13% 160
2025
Q4
$11M Buy
107,942
+21
+0% +$2.06K 0.18% 93
2025
Q3
$11.4M Buy
107,921
+5,676
+6% +$588K 0.23% 76
2025
Q2
$11M Sell
102,245
-15,764
-13% -$1.6M 0.23% 74
2025
Q1
$11.9M Sell
118,009
-21,676
-16% -$2.18M 0.26% 74
2024
Q4
$12.5M Buy
139,685
+44,193
+46% +$3.89M 0.23% 79
2024
Q3
$8M Sell
95,492
-17,864
-16% -$1.41M 0.17% 96
2024
Q2
$8.73M Buy
+113,356
New +$8.3M 0.19% 96

Other funds holding BSX

Mizuho Securities USA's BSX Position: Q2 2026 in Review

Mizuho Securities USA increased its Boston Scientific (BSX) stake by 30% in Q2 2026, buying an estimated $1.45M and bringing the position to 116,365 shares worth $4.97M. The position accounts for 0.08% of the portfolio, ranked #238.

Mizuho Securities USA first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.5M in Q4 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mizuho Securities USA held 116,365 shares of Boston Scientific worth $4.97M as of Q2 2026.
  • Mizuho Securities USA bought 26,710 Boston Scientific shares in Q2 2026, an estimated $1.45M.
  • Boston Scientific made up 0.08% of Mizuho Securities USA's portfolio in Q2 2026, its #238 holding.
  • Mizuho Securities USA first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Boston Scientific position peaked at $12.5M in Q4 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.